We were honored to welcome Nobel Prize laureate, Professor of Chemistry at Stanford University, and Veranova Advisory Board member, Carolyn Bertozzi to our SCALE 2025 Symposium event in July.
Listen to Carolyn’s talk where she discusses her decades-long work developing bioorthogonal and click chemistries, and how these innovations are enabling the construction of complex therapeutic modalities across pharma today.
Read our latest white paper highlighting critical analytical techniques necessary for the characterization of ADCs, emphasizing their physicochemical properties, biological activity, stability assessments, and regulatory implications.
In recent years, interest in psychedelics for therapeutic use has increased. Among these is psilocybin, the world’s most studied psychedelic compound for the treatment of mental health conditions. This Expert Insight explores the potential of this molecule, and the challenges associated with synthesizing it at scale.
Discover new ways to advance your science with Veranova.
Contact us